Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals

Bulletin of the World Health Organization

Volumn 86, Issue 12, 2008, Pages 970-977

  Charles, Macarthur ^a   Noel, Francine ^a   Leger, Paul ^a   Severe, Patrice ^a   Riviere, Cynthia ^a   Beauharnais, Carole Anne ^a   Miller, Erica ^b   Rutledge, John ^b   Bang, Heejung ^b   Shealey, Wesley ^c   D'Aquila, Richard T ^c   Gulick, Roy M ^b   Johnson Jr , Warren D ^b   Wright, Peter F ^c   Pape, Jean William ^a   Fitzgerald, Daniel W ^b  

^a Department of Adolescent Medicine   (Haïti)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADOLESCENT SEXUALITY; CONCENTRATION (COMPOSITION); DISEASE TREATMENT; DRUG RESISTANCE; ENZYME ACTIVITY; EPIDEMIC; HUMAN IMMUNODEFICIENCY VIRUS; PLASMA; RNA; SURVIVAL; YOUNG POPULATION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HAITI; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MUTATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREGNANT WOMAN; PROBABILITY; SEXUAL INTERCOURSE; SEXUALITY; SURVIVAL; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; DRUG RESISTANCE, MULTIPLE, VIRAL; FEMALE; HAITI; HIV INFECTIONS; HIV-1; HUMANS; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RNA; SURVIVAL ANALYSIS; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 57149110618     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.07.050120     Document Type: Article

References (50)

1. Pan American Health Organization. Country Health Profile, Haiti. Washington, DC: PAHO; 2002. Available from: http://www.paho.org/English/DD/AIS/ cp_332.htm [accessed on 22 October 2008].
2. Blum RW, Nelson-Mmari K. The health of young people in a global context. J Adolesc Health 2004;35:402-18. PMID:15488435
3. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update, December 2006. Geneva: UNAIDS; 2006. Available from: http://data.unaids.org/ pub/EpiReport/2006/02-Global_Summary_2006_EpiUpdate_eng.pdf. [accessed on 22 October 2008].
4. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33. PMID:9287227 doi:10.1056/NEJM199709113371101
5. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-9. PMID:9287228 doi:10.1056/NEJM199709113371102
6. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60. PMID:9516219 doi:10.1056/NEJM199803263381301
7. Flynn PM, Rudy BJ, Douglas SD, Lathey J, Spector SA, Martinez J, et al. Virologic and immunologic outcomes after 24 weeks in HIV-1 infected adolescents receiving highly active antiretroviral therapy. J Infect Dis 2004;190:271-9. PMID:15216461 doi:10.1086/421521
8. Murphy DA, Belzer M, Durako SJ Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR, et al. Longitudinal antiretroviral adherence among adolescents infected with HIV. Arch Pediatr Adolesc Med 2005;159:764-70. PMID:16061785 doi:10.1001/archpedi.159.8.764
9. Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS 2001;15:1369-77. PMID:11504958 doi:10.1097/ 00002030-200107270-00006
10. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006;367:1335-42. PMID:16631912 doi:10.1016/S0140-6736(06)68580-2
11. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, et al. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006;367:817-24. PMID:16530575 doi:10.1016/S0140-6736(06)68337-2
12. Weidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, Were W, et al. Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 2006;368:1587-94. PMID:17084759 doi:10.1016/S0140- 6736(06)69118-6
13. Peck R, Fitzgerald DW, Liautaud B, Deschamps MM, Verdier MM, Beaulieu ME, et al. The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing (VCT): evaluation of a 15-year experience in Haiti, 1985-2000. J Acquir Immune Defic Syndr 2003;33:470-5. PMID:12869835
14. Scaling up antiretroviral therapy in resource-limited settings. Geneva: World Health Organization; 2004.
15. Severe P, Leger P, Charles M, Noel F, Bonhomme G, Bois G, et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti. N Engl J Med 2005;353:2325-34. PMID:16319381 doi:10.1056/NEJMoa051908
16. George E, Noel F, Bois G, Cassagnol R, Estavien L, de Matheis Rouzier P, et al. Antiretroviral therapy for HIV-1 infected children in Haiti. J Infect Dis 2007;195:1411-8. PMID:17436220 doi:10.1086/514823
17. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 2000;356:1470-4. PMID:11081529 doi:10.1016/S0140-6736(00)02870-1
18. Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol 2004;57:1107-10. PMID:15528063 doi:10.1016/j.jclinepi.2004.04.002
19. Kitahata MM, Reed SD, Dillingham PW, Van Rompaey SE, Young AA, Harrington RD, et al. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS 2004;15:803-10. PMID:15601486 doi:10.1258/0956462042563666
20. Johnson VA, Brun-Vezinet F, Clotet B, Kuritzkes DR, Pillay D, Schapiro JM, et al. Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med 2006;14:125-30. PMID:16946457
21. The International CD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 2003.
22. Bracken A. Haiti's children pay the price of poverty. NACLA Arch 2006;39:22-5.
23. Farmer P, Leandre F, Mukherjee JS, Claude M, Nevil P, Smith-Fawzi MC, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001;358:404-9. PMID:11502340 doi:10.1016/S0140-6736(01)05550-7
24. Wharton B, Wharton P. Nutrition in adolescence. Nutr Health 1987;4:195-203. PMID:3554043
25. Hall A, Bobrow E, Brooker S, Jukes M, Nokes K, Lambo J, et al. Anaemia in schoolchildren in eight countries in Africa and Asia. Public Health Nutr 2001;4:749-56. PMID:11415481
26. Kurz KM. Adolescent nutritional status in developing countries. Proc Nutr Soc 1996;55:321-31. PMID:8832803 doi:10.1079/PNS19960032
27. DeMaeyer E, Adiels-Tegman M. The prevalence of anaemia in the world. World Health Stat Q 1985;38:302-16. PMID:3878044
28. Massawe SN, Ronquist G, Nystrom L, Lindmark G. Iron status and iron deficiency anaemia in adolescents in a Tanzanian suburban area. Gynecol Obstet Invest 2002;54:137-44. PMID:12571434 doi:10.1159/000067879
29. Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, et al. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2004; 37:1245-52. PMID:15385731 doi:10.1097/01.qai.0000134759.01684.27
30. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998;91:301-8. PMID:9414298
31. Moore RD. Human immunodeficiency virus infection, anemia, and survival. Clin Infect Dis 1999;29:44-9. PMID:10433563 doi:10.1086/520178
32. Deschamps MM, Fitzgerald DW, Pape JW, Johnson WD Jr. HIV infection in Haiti: natural history and disease progression. AIDS 2000;14:2515-21. PMID:11101063 doi:10.1097/00002030-200011100-00014
33. Badri M, Ehrlich R, Wood R, Pulerwitz T, Maartens G. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. Int J Tuberc Lung Dis 2001;5:225-32. PMID:11326821
34. Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Michael NL, et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 2000;14:1219-28. PMID:10894287 doi:10.1097/00002030-200006160-00020
35. Day JH, Grant AD, Fielding KL, Morris L, Moloi V, Charalambous S, et al. Does tuberculosis increase HIV load? J Infect Dis 2004;190:1677-84. PMID:15478075 doi:10.1086/424851
36. Nelson EA, Olukoya A, Scherpbier RW. Towards an integrated approach to lung health in adolescents in developing countries. Ann Trop Paediatr 2004;24:117-31. PMID:15186540 doi:10.1179/027249304225013394
37. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-8. PMID:4810628
38. Zeidberg LD, Gass RS, Dillon A, Hutcheson RH. The Williamson County Tuberculosis Study. A twenty-four-year epidemiologic study. Am Rev Respir Dis 1963;87:1-88. PMID:14003375
39. Donald PR, Beyers N. Adolescent tuberculosis. S Afr Med J 1996;86:231-3. PMID:8658287
40. Comstock GW, Ferebee SH, Hammes LM. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 1967;95:935-43. PMID:6026165
41. Smith MH. Tuberculosis in adolescents: characteristics, recognition, management. Clin Pediatr (Phila) 1967;6:9-15. PMID:5297237
42. Rudy BJ, Lindsey JC, Flynn PM, Bosch RJ, Wilson CM, Hughes ME, et al. Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort. AIDS Res Hum Retroviruses 2006;22:213-21. PMID:16545007 doi:10.1089/aid.2006.22.213
43. Murphy DA, Wilson CM, Durako SJ, Muenz LR, Belzer M. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care 2001;13:27-40. PMID:11177463 doi:10.1080/09540120020018161
44. Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, et al. Clinical progression and virologic failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV cohort study. Lancet 1999;353:863-8. PMID:10093977 doi:10.1016/S0140-6736(99)01122-8
45. Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine C, Costagliola D, et al. Clinical outcomes of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann Intern Med 2000;133:401-10. PMID:10975957
46. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30. PMID:10877736
47. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-9. PMID:10738050 doi:10.1056/NEJM200003303421303
48. Staples B, Bravender T. Drug compliance in adolescents: assessing and managing modifiable risk factors. Paediatr Drugs 2002;4:503-13. PMID:12126454
49. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004;42:200-9. PMID:15076819 doi:10.1097/01.mlr.0000114908.90348.f9
50. Puccio JA, Belzer M, Olson J, Martinez M, Salata C, Tucker D, et al. The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: a pilot study. AIDS Patient Care STDS 2006;20:438-44 10.1089/apc.2006.20.438. PMID:16789857 doi:10.1089/apc.2006.20.438